Global Hemostat Powders Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The hemostat powders market is anticipated to grow at a significant CAGR of 5.6% during the forecast period (2022-2028). Hemostat powder is used to stop bleeding in the gastrointestinal tract. Bleeding in the upper gastrointestinal tract and lower gastrointestinal tract are mostly caused by peptic ulcers, and inflammatory bowel disease syndrome. Hemostatic powders have been used as a handy method in case of GI bleeding for quite some time. Some hemostat powders which are used in bleeding are TC-325, Ankaferd Blood Stopper, and Endoclot. Ankaferd Blood Stopper has been approved by the Turkish Food and Drug Administration. These hemostatic powders work as adhesives to bleeding sites where there is a blood flow. Apart from this, these powders absorb the moisture which is present at the bleeding site. The hemostatic powder absorbs or dehydrates the water molecule which is present. After working on the bleeding site, they complete the hemos tatic effect. These powders may also have been working on the platelet aggregation and activation of clotting factors.

The development of effective drugs that can be used as a treatment for GI bleeding is expected to drive the market during the forecast period. For instance, in Oct 2021, Allen Wang and Gary Zhang would be receiving a patent award for their innovation. They have developed an Oxidized hemostatic powder which is primarily made to stop bleeding in the gastrointestinal tract or surgical injuries. The powder which has been developed by Wang and Zhang is quite different from previous alternatives present in this category. They both developed this hemostatic material from oxidized regenerated cellulose which is mostly there with a surgeon when he performs any surgery.A major component of this powder is aggregates of fine fibers present in oxidized regenerated cellulose. This powder has proven effective in reducing the time of hemostasis. In surgery, this powder was found effective in reducing the bleeding. The trademark for this newly developed hemostat powder is SURGICEL.

Some major players in the marketinclude C.R. Bard Inc., Baxter International Inc., Medical Device Business Services, Inc., Pfizer Inc. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, Baxter International Inc. has announced the acquisition of Per Clot Polysaccharide Hemostatic System from Cryo Life, Inc.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-C.R. Bard Inc., Baxter International Inc., Teleflex Inc., Medtronic plc, Medical Device Business Services, Inc., Pfizer Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Hemostat Powders Market Report by Segment

By Application

• Upper GI Tract
• Lower GI Tract
• Surgery

By End-User

• Hospital
• Clinic
• Others